FDA Investigator Madushini Dharmasena, PhD
Madushini Dharmasena, PhD has conducted inspections on 19 sites in 14 countries as of 29 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
19
Last Inspection Date:
29 Feb 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
India,
Korea (Republic of),
United States of America,
Ireland,
Belgium,
Switzerland,
Singapore,
Australia,
Iceland,
United Kingdom of Great Britain and Northern Ireland,
Netherlands,
Israel,
Taiwan,
Japan
FDA Investigators that have inspected at least one site in common with Madushini Dharmasena, PhD:
Ademola O Daramola,
Alice S Tsao,
Alicia M Mozzachio,
Amy Devlin, PhD,
Anastasia G Lolas,
Andrea Siegel, PhD,
Anissa M Vargas,
Anita Narula, PhD,
Anjali Shukla, PhD,
Ann Marie Montemurro,
Anthony A Charity,
Antonina Aydanian,
Arnold Seo, PhD,
Arsen Karapetyan,
Ashutosh Rao, PhD,
Azza Talaat,
Barbara J Rincon,
Bijoy Panicker,
Bingchen Du, PhD,
Bo Chi, PhD,
Brandon C Heitmeier,
Brian M Janelsins, PhD,
Brooke K Higgins,
Candace Y Gomez Broughton,
Carla J Lundi,
CDR Donald Ertel,
Chaltu Nwakijra,
Charisse K Green,
Chen Sun, PhD,
Chikako Torigoe, PhD,
Christina V Santos,
Cynthia Jim, CSO,
David Doleski,
Deborah Schmiel, PhD,
Dennis Cantellops Paite,
Diane L Raccasi,
Dogbeda F Mackenzie,
Donald C Obenhuber, PhD,
Dr. Jun Liu, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Willie Wilson, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Eileen A Liu,
Ephrem Hunde, PhD,
Erika V Butler,
Ewa Marszal, PhD,
Frances Namuswe, PhD,
Gene D Arcy,
Gerald B Seaborn, Jr,
Guerlain Ulysse,
Gunther Boekhoudt, PhD,
Hailin Wang (Sheena), PhD,
Hamet M Toure, PharmD MPH,
Herbert M Corbello,
Hyung Yul Lee,
Ivis L Negron,
J David Doleski,
Jacek Cieslak, PhD,
Jacqueline Mdiaz Albertini,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Swisher, PhD,
Joanne M Schlossin,
John F Cipollo,
Jonathan W Chapman,
Jorge L Guadalupe,
Jose Acruz Gonzalez,
José E Meléndez,
Juhong Liu, PhD,
Junho Pak,
Justin A Boyd,
Kalavati Suvarna, PhD,
Katherine Szestypalow,
Kathy Lee,
Kelly R Lewis,
Kent C Faul,
Kevin A Gonzalez,
Larry K Austin,
Laura Fontan, MS,
Laurel A Beer,
Lei Zhang, PhD,
Leonard H Lavi,
Libia M Lugo,
Linda Thai,
Lindsey S Fleischman,
Lixin Xu, MD, PhD,
Lori J Silverstein,
LT Richard A Lyght,
Lucila B Nwatu,
Lynda L Perry, PhD,
Maria Gutierrez Hoffman, PhD,
Maria Gutierrez Lugo, PhD,
Maria Joselopez Barragan, PhD,
Marion Michaelis,
Mary E Farbman, PhD,
Mary E Storch,
Maryam Tabatabaie,
Matthew B Casale,
Mekonnen Lemma Dechassa, PhD,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael Shanks, MS,
Michele L Obert,
Mihaly S Ligmond,
Monica Markovski, PhD,
Mra Davism,
Mra M Barbosar,
Mra Mcculloughj,
Mra Munizn,
Nadeem I Chaudhry,
Nancy A Bellamy,
Nancy G Schmidt,
Nancy T Waites,
Nebil A Oumer,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Patricia H Dlugosz,
Patrick C Klotzbuecher,
Patrick J Lynch,
Patsy J Domingo,
Paula A Trost,
Peggy M Speight,
Peter R Lenahan,
Phillip Angart, PhD,
Prabhu P Raju,
Rachel C Harrington,
Rajiv R Srivastava,
Ramesh Potla, PhD,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Richard Heath Coats,
Richard Ledwidge (nmi), PhD,
Riley C Myers, PhD,
Robert D Tollefsen,
Robert J Ham,
Robert Rodriguez,
Roger F Zabinski,
Rose Ashley,
Santos E Camara,
Sarah Arden,
Sarah Johnson, PhD,
Sarah Kennett, PhD,
Scott C Lute,
Scott E Norris,
Scott R Nichols, PhD,
Scott T Ballard,
Sean Fitzsimmons,
Shadia Zaman, PhD,
Simone E Pitts,
Stephen D Brown,
Steven E Bowen, PhD,
Steven E Kane,
Steven Fong, MS, PhD,
Steven M Weinman,
Susan M Jackson,
Susan P Bruederle,
Teegan Dellibovi Ragheb, PhD,
Thomas E Friel,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Tina S Roecklein,
Tracey L Harris,
Uduak M Inokon,
Vaishali J Patel,
Virginia Carroll, PhD,
Viviana Matta,
Wayne E Seifert,
Wendy G Tan, PhD,
William Hallett, PhD,
Xiaokuang Lai, PhD,
Xiaoshi N Wang,
Xu Michael Di, PhD,
Yanming An, PhD,
Yetao Jin, PhD,
Ying Xin Fan, PhD,
Ying Zhang,
Yonggang Wang, PhD,
Yun Wu, PhD,
Zhong Li, PhD
Madushini Dharmasena, PhD's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more